Fact-checked by Grok 2 weeks ago

Medium-chain triglyceride

Medium-chain triglycerides (MCTs) are a class of consisting of a backbone esterified with three medium-chain fatty acids, typically those containing 6 to 12 carbon atoms, such as (C6:0), (C8:0), (C10:0), and sometimes (C12:0). These fats are distinguished by their shorter chain length compared to long-chain triglycerides (LCTs), which results in unique metabolic properties, including rapid by pancreatic lipases, direct absorption into the , and transport to the liver without requiring salts or carnitine for processing. Unlike LCTs, MCTs are liquid at and yield approximately 8.4 kcal/g of energy, making them a readily available source that bypasses typical fat storage pathways. MCTs occur naturally in certain foods, primarily derived from (46–54% lauric acid), (45–50% lauric acid), and to a lesser extent in bovine fat (2.5–4% lauric acid), though commercial MCTs are predominantly C8:0 and C10:0 to optimize purity and functionality. They are produced industrially through processes like of coconut or followed by and re-esterification, often using enzymatic methods such as lipases or chemical catalysts, achieving high yields up to 99.7%. The U.S. recognizes MCTs as (GRAS) for use in , with requiring at least 90% of fatty acids to be C8:0 or C10:0, and trace amounts of other chains like C6:0 (≤1.8%) and C12:0 (≤1.5%). In applications, MCTs are widely incorporated into medical nutrition products, such as enteral formulas for patients with fat malabsorption, preterm infant formulas (up to 50% of fat content), and ketogenic diets for management, where they promote body production for brain energy. They also serve as functional ingredients in foods like cooking oils, bakery items, and supplements to enhance energy expenditure, support by increasing fat oxidation (up to 5–8 times faster than LCTs), and improve nutrient absorption, including calcium and . Physiologically, MCTs have demonstrated benefits in clinical settings, such as elevating beta-hydroxybutyrate levels in patients at 30 g/day doses and boosting muscle strength and levels in the elderly at 6 g/day, while exhibiting antimicrobial effects against pathogens like . Safety studies confirm no observed levels up to 9.5–20 g/kg body weight/day in animals and humans, with only minor, transient gastrointestinal effects at high intakes.

Definition and Chemistry

Definition and Nomenclature

Medium-chain triglycerides (MCTs) are a subclass of triglycerides defined as esters formed by the bonding of one molecule with three medium-chain fatty acids (MCFAs), each containing 6 to 12 carbon atoms in their aliphatic tails. This structure contrasts with short-chain triglycerides (SCTs), which incorporate fatty acids of 2 to 5 carbon atoms, and long-chain triglycerides (LCTs), featuring fatty acids with 13 or more carbon atoms. The shorter chain length of MCTs facilitates quicker enzymatic by pancreatic lipases and direct into the , unlike LCTs that require emulsification by salts and via the lymphatic system. The term "medium-chain" in MCT nomenclature originates from the standardized classification of fatty acids by chain length, as established in lipid chemistry guidelines, where MCFAs specifically denote saturated or unsaturated chains between 6 and 12 carbons. Common abbreviations include MCT for the triglycerides and MCFA for the constituent fatty acids, with specific compounds named systematically (e.g., tricaprylin for the triester of caprylic acid). This descriptive nomenclature emphasizes metabolic and physical distinctions rather than a single chemical formula, given the variability in fatty acid composition within the class. MCTs were first isolated in the 1950s during the of for industrial purposes, marking their initial recognition as a distinct fraction. By the , their clinical potential was explored, leading to early medical applications in managing fat disorders due to their enhanced digestibility.

Chemical Structure

Medium-chain triglycerides (MCTs) consist of a esterified with three medium-chain s, each having a chain length of 6 to 12 carbon atoms. The general formula for triglycerides, including MCTs, is \ce{(RCOO)3C3H5}, where R denotes the saturated alkyl chain derived from the , typically comprising 5 to 11 carbon atoms for medium-chain variants. The molecular structure features three ester linkages, formed by the condensation of the hydroxyl groups on the glycerol backbone—a three-carbon alcohol—with the carboxyl groups of the medium-chain fatty acids. These fatty acids in MCTs are predominantly saturated, meaning they lack carbon-carbon double bonds, which contributes to the overall chemical stability of the molecule. For instance, the glycerol is bonded at its sn-1, sn-2, and sn-3 positions to the acyl chains, resulting in a non-polar, hydrophobic triester. A representative example of an MCT is tricaprylin (also known as glycerol trioctanoate), where all three chains are (octanoic acid, C8:0). Its structure can be depicted as: \ce{CH2(OCO(CH2)6CH3)-CH(OCO(CH2)6CH3)-CH2(OCO(CH2)6CH3)} with a molecular of \ce{C27H50O6}. This symmetric molecule exemplifies the compact nature of MCTs compared to those with longer chains. Commercial MCT preparations are typically refined to high purity, consisting almost entirely of triglycerides derived from (C8:0) and capric (C10:0) acids, often in ratios such as 60:40 or 70:30, with minimal presence of other . This composition ensures uniformity and resistance to oxidative degradation due to the saturated bonds.

Medium-Chain Fatty Acids

Medium-chain fatty acids (MCFAs) are saturated fatty acids containing 6 to 12 carbon atoms, serving as the building blocks of medium-chain triglycerides (MCTs). The key MCFAs in MCTs include , , , and , each characterized by its specific chain length and chemical properties. These acids are typically straight-chain and fully saturated, contributing to the overall stability and metabolic behavior of MCT molecules. The following table summarizes the primary MCFAs, their notations, and formulas:
Common NameSystematic NameNotationMolecular FormulaStructural Formula
Hexanoic acidC6:0C₆H₁₂O₂CH₃(CH₂)₄COOH
Octanoic acidC8:0C₈H₁₆O₂CH₃(CH₂)₆COOH
Decanoic acidC10:0C₁₀H₂₀O₂CH₃(CH₂)₈COOH
Dodecanoic acidC12:0C₁₂H₂₄O₂CH₃(CH₂)₁₀COOH
In commercial MCT oils, such as those derived from fractionated , caprylic (C8:0) and capric (C10:0) acids predominate, often comprising 50-80% of the total fatty acid content, with common ratios ranging from 60:40 to 70:30 (C8:C10). Shorter-chain MCFAs like caproic (C6:0) and caprylic (C8:0) exhibit notable , which allows them to contribute to flavor profiles in and other food products through their release of characteristic or cheesy notes. (C12:0), in contrast, demonstrates antimicrobial properties primarily through its disruption of microbial cell membranes, a that impairs bacterial without requiring conversion to other derivatives. Definitions of MCFAs vary slightly across sources, with some encompassing the full range from C6:0 to C12:0, while others restrict the category to C6:0-C10:0, excluding due to its longer chain and differing metabolic handling akin to long-chain fatty acids. These fatty acids are esterified to a backbone to form the of MCTs.

Sources and Production

Natural Sources

Medium-chain triglycerides (MCTs) are primarily derived from natural plant and animal sources, with the highest concentrations found in certain tropical oils and fats. is one of the richest sources, containing approximately 60% medium-chain fatty acids (MCFAs) as a percentage of total fatty acids, predominantly (C12:0, about 48.5%), along with smaller amounts of (C8:0) and (C10:0) comprising around 10% combined. similarly serves as a significant source, with about 54.6% MCFAs, including roughly 47.8% , 3.3% , and 3.5% . In animal-derived sources, contains 7–23% MCFAs (C8:0 to C14:0) of total fatty acids, with (C12:0) and (C14:0) being predominant at approximately 5% and 6%, respectively, alongside notable levels of (C10:0). These MCFAs in provide a rapid energy source for due to their quick absorption into the and direct oxidation in the liver, supporting early growth and brain development through —a feature potentially linked to evolutionary adaptations for . Cow's milk fat includes lower but measurable levels of MCFAs, totaling around 7–8% of total fatty acids, with (1.3–1.4%), (2.7–3.3%), and (2.9–3.8%). Minor sources of MCTs include dairy products such as and cheese, which reflect the MCFA profile of cow's fat (e.g., C6:0 at 2.4%, caprylic at 1.4%, capric at 2.7%, and lauric at 3.3%).

Commercial Production

Commercial production of medium-chain triglycerides (MCTs) primarily relies on of natural oils rich in medium-chain fatty acids (MCFAs), such as and oils, which serve as starting materials. The process typically begins with of the oil to liberate free fatty acids, followed by distillation—often steam or —to separate the MCFA fraction (primarily , C8:0, and , C10:0) based on differing boiling points. This distillate, containing 70-100% MCFAs depending on the refinement level, is then purified and re-esterified with to form MCTs, yielding a clear, odorless oil with high purity (up to 99% for pharmaceutical grades). Interesterification provides an alternative route for producing MCTs or structured incorporating MCFAs, involving the enzymatic or chemical rearrangement of fatty acids between triglycerides. Enzymatic interesterification, using immobilized lipases like Lipozyme 435, catalyzes the of MCFAs from distillates with long-chain fatty acids from other vegetable oils, achieving yields of up to 75% MCT content under optimized conditions (e.g., 90°C for 5 hours). Chemical methods employ catalysts for but may introduce trans fats, making enzymatic approaches preferred for food-grade products with purity levels around 70-90%. This method allows customization of MCT profiles for specific applications while utilizing byproducts from . Emerging since 2020, microbial production via chain elongation offers a sustainable synthetic route for MCFAs, which can be esterified into MCTs, using anaerobic bacteria to extend (e.g., ) with from organic waste streams. Reverse β-oxidation in mixed cultures or pure strains like Clostridium kluyveri produces C6-C8 MCFAs at rates up to 21 g COD/L/day, with recent isolations such as Caproicibacter fermentans enhancing specificity and yields from feedstocks like dairy wastewater. While not yet dominant commercially due to scale-up challenges like product toxicity, pilot processes demonstrate potential for bio-based MCTs with 80-95% purity after extraction and esterification. MCTs are commercialized in various forms to suit different uses, including liquid oils (70-100% MCT content for food-grade) and emulsified powders (e.g., spray-dried with carbohydrates or proteins for 50-70% MCT loading in nutritional supplements). Pharmaceutical-grade MCTs achieve 99%+ purity through advanced and meet standards, while food-grade variants from typically contain 60-80% C8/C10 with trace . These forms ensure stability and , with production scales reaching thousands of tons annually from coconut-derived sources.

Properties

Physical Properties

Medium-chain triglycerides (MCTs) appear as colorless to pale yellow oils at , remaining in a liquid state due to their low melting points, typically below 10°C for common formulations like caprylic/capric triglycerides. These oils exhibit low , ranging from 27 to 33 centipoise at 20°C, and a of 0.930 to 0.960 g/mL at the same temperature, facilitating easy handling and flow in various applications. MCTs are insoluble in but highly soluble in alcohols, hydrocarbons, and other organic solvents owing to their relatively greater hydrophilicity compared to long-chain triglycerides. MCTs demonstrate high oxidative stability, with rancimat induction times exceeding 100 hours at 100°C and low values (≤1.0 meq/kg), attributed to their saturated nature and shorter chain lengths that reduce susceptibility to peroxidation relative to unsaturated fats. Their , approximately 160–177°C, supports moderate-heat uses without rapid degradation. In pure form, MCTs possess a mild, odor and taste, though variants rich in fatty acids may exhibit subtle fruity due to the influence of chain length on sensory profiles.

Metabolic Properties

Medium-chain triglycerides (MCTs) are rapidly digested in the primarily through by pancreatic lipases in the and , a process that differs from long-chain triglycerides (LCTs), which require emulsification by salts for efficient breakdown. This enzymatic releases free medium-chain fatty acids (MCFAs), such as (C8:0), which are more hydrophilic and thus more readily processed without the need for formation. Following digestion, MCFAs from MCTs are absorbed directly into the as free fatty acids, bypassing the and pathway typically used by LCTs. This direct route results in highly efficient for MCTs (often >95%), which is particularly advantageous compared to LCTs in individuals with fat malabsorption, where LCT may be 70-90%. In the liver, MCFAs undergo rapid beta-oxidation in the mitochondria, converting them to and subsequently to without the carnitine shuttle required for LCTs. For example, (C8H16O2) is oxidized via the following pathway, ultimately yielding through complete combustion: \text{C}_8\text{H}_{16}\text{O}_2 + 11\text{O}_2 \rightarrow 8\text{CO}_2 + 8\text{H}_2\text{O} + \text{[energy](/page/Energy) (ATP)} This process produces ketones rapidly, providing an immediate source. The yield from MCTs is approximately 8.3 kcal/g, lower than the 9 kcal/g from LCTs, due to their efficient oxidation and reduced storage as . Additionally, MCT metabolism exhibits a thermogenic , increasing expenditure by about 5-10% compared to LCTs, as evidenced by postprandial oxygen consumption rising 12% above basal levels with MCTs versus 4% with LCTs. Recent from 2023 indicates MCTs partially activate PPAR-γ, enhancing and glucose in obese models. Studies also indicate that MCT can lead to reduced subsequent , though effects on subjective and levels are inconsistent.

Applications

Nutritional and Dietary Uses

Medium-chain triglycerides (MCTs) are incorporated into various nutritional and dietary strategies to support general and , leveraging their efficient provision without the digestive burden of longer-chain fats. In everyday diets, MCTs are valued for promoting and stable levels, making them suitable for low-carbohydrate or ketogenic eating patterns where quick absorption is beneficial. Recommended daily intake of MCTs typically ranges from 5 to 20 grams to achieve benefits such as enhanced and reduced while minimizing gastrointestinal upset, which can occur at doses exceeding 30 grams. This amount aligns with common practices, such as adding 1 to 2 tablespoons (approximately 14 to 28 grams) of MCT oil to in the Bulletproof , a popular high-fat, low-carb regimen that emphasizes sustained mental clarity and appetite control through blended beverages. Their rapid enables these effects by providing readily available fuel, bypassing typical pathways. In , MCTs offer advantages over long-chain fats by increasing and energy expenditure, leading to modest reductions in body weight. A 2024 meta-analysis of randomized controlled trials found that MCT-enriched diets resulted in approximately 1.53% greater compared to long-chain diets over periods of about 12 weeks, equating to roughly 0.5 to 1 for individuals with or , attributed to heightened postprandial and reduced ad libitum consumption. For athletic performance, supplementation with 10 to 30 grams of MCTs delivers quick energy by promoting production, sparing stores during activities and supporting sustained output without performance dips. A 2025 study demonstrated synergistic benefits when combining MCT supplementation with resistance exercises like chair stands, enhancing muscle recovery through improved replenishment and reduced inflammation markers in active populations. MCTs are widely added to products as clean-label fats, providing a neutral and stable in items like baked goods, sports bars, and meal replacements, where they serve as a versatile alternative to hydrogenated oils while maintaining product and nutritional appeal. In calorie-restricted diets, incorporating MCTs enhances , potentially reducing overall daily energy intake by 100 to 200 kilocalories, as evidenced by a 2020 and on acute effects, with supporting data from 2023 trials confirming sustained appetite suppression in weight-loss protocols. Consumer trends reflect growing demand for vegan-friendly MCT formulations, particularly powders derived from or sources, which surged post-2020 amid rising interest in plant-based and wellness supplements. The global MCT oil and powder market has expanded rapidly, projected to reach approximately $973 million by 2025, driven by innovations in microencapsulated, dairy-free options for shakes and bars.

Medical and Therapeutic Uses

Medium-chain triglycerides (MCTs) have been employed in clinical settings since the 1960s to address syndromes, including and , where impaired pancreatic enzyme function limits long-chain fat digestion. Early studies demonstrated that MCTs, absorbed directly into the rather than via lymphatics, improve fat utilization and reduce in these patients. Current 2023 guidelines from the European Society for and Metabolism (ESPEN), in collaboration with ESPGHAN and ECFS, recommend formula diets with 30-50% MCTs as part of high-energy, high-fat regimens for to enhance caloric intake and growth while minimizing complications. For , ESPEN practical guidelines endorse peptide-based enteral feeds enriched with MCTs (up to 50% of fat content) to alleviate postprandial pain, support weight maintenance, and correct nutrient deficiencies, with efficacy confirmed through reduced fecal fat loss and improved nutritional biomarkers. In management, MCTs form the basis of the , supplying 20-60% of daily calories to promote and exert effects independent of restriction. Clinical trials indicate that this approach achieves at least a 50% reduction in approximately 30% of drug-resistant pediatric and adult patients, with some experiencing complete freedom. A 2022 study on supplemental MCT oil in adults with refractory reported an estimated 42% overall reduction in frequency (p < 0.0001), attributed to rapid production enhancing neuronal stability. The Foundation notes that incorporating MCTs yield ≥50% reduction in over half of children, positioning MCT variants as a tolerable option for long-term adherence compared to classical protocols. For neurodegenerative conditions, a 2025 review on underscores MCTs' role in by generating as an alternative brain fuel, bypassing glucose hypometabolism in affected regions. This leads to modest cognitive enhancements, such as improved and executive function scores on standardized tests like the MMSE, particularly in stages where utilization correlates with better cerebral energy rescue. A concurrent 2025 of interventions, including MCT-derived sources, confirmed a significant but small effect on overall cognitive performance (standardized mean difference ≈0.2), with no adverse events beyond mild gastrointestinal upset. MCT supplementation shows promise in metabolic disorders, with research indicating improved insulin sensitivity in patients. In preclinical models, a 2023 study on a ester and MCT supplement demonstrated effects in female rats at lower doses via potential adenosinergic modulation, though human translation remains exploratory. Emerging evidence highlights MCTs' adjunctive roles in and . Preclinical studies suggest MCTs exhibit anticancer effects, including induction in colon cancer cells. For , a 2023 randomized trial found that 6 g daily MCTs combined with moderate-intensity increased by approximately 1.7 kg after 12 weeks among healthy middle-aged and older adults, with improvements in functional tests like Timed Up & Go outperforming exercise alone. Regarding safety, MCTs are well-tolerated at doses up to 30g per day but may provoke gastrointestinal side effects like , , and cramping at higher intakes due to rapid colonic fermentation. They are contraindicated in severe , as MCT metabolism burdens hepatic beta-oxidation pathways, potentially exacerbating or failure in conditions like .

Pharmaceutical and Industrial Uses

Medium-chain triglycerides (MCTs) serve as versatile excipients in pharmaceutical formulations, particularly for enhancing the of lipophilic drugs in capsules and tablets. For instance, Kollisolv® MCT 70, a medium-chain triglyceride composed primarily of caprylic and esters, is widely used as a and solubilizer due to its high solubilization capacity and low , enabling better of poorly water-soluble active ingredients. This oily liquid also functions as a and penetration enhancer in solid , improving processes and drug release profiles. In , MCTs are incorporated into intravenous lipid emulsions, often in mixtures with long-chain triglycerides (LCTs) at ratios such as 20% MCT and 80% LCT, to provide balanced energy sources while minimizing metabolic burdens. These emulsions, introduced in the 1980s and refined in the , offer improved tolerability compared to pure LCT formulations by facilitating faster clearance and reducing risks in clinical settings. MCT-based nanoemulsions have emerged as effective systems for , significantly boosting the of lipophilic compounds through enhanced absorption across biological barriers. Recent studies demonstrate that MCT-stabilized nanoemulsions can increase by up to 10.6-fold by improving and lymphatic uptake, representing a substantial enhancement over conventional formulations. This approach leverages the physical stability of MCTs, such as their low , to form stable droplets that protect drugs from and promote targeted delivery. In industrial applications, MCTs act as non-greasy lubricants in , including conditioners, where they provide emolliency and spreadability without residue, enhancing product and / compatibility. Caprylic acid-derived MCTs (C8), valued for their volatility, serve as flavor carriers in perfumes, enabling efficient dispersion of aromatic compounds while contributing subtle fatty notes. Additionally, MCTs function as additives, where their incorporation reduces emissions like and by promoting complete in engines. High-purity technical grades of MCTs are utilized in cleaning as sustainable, biodegradable solvents that effectively remove residues without damaging sensitive components, aligning with growing demand for eco-friendly alternatives to petroleum-based cleaners. The market for such MCT applications is projected to expand significantly by , driven by their renewability and lower environmental impact compared to traditional solvents. Regulatory frameworks support these uses, with the U.S. FDA affirming MCTs as (GRAS) for direct food and pharmaceutical applications since the 1990s, following earlier evaluations in the GRAS review process. In the , MCTs comply with established safety standards, though novel fermented variants require specific approvals under the Regulation to ensure compliance with updated specifications.

References

  1. [1]
    Triglycerides of medium-chain fatty acids: a concise review - NIH
    Jun 22, 2022 · Medium-chain triglycerides contain medium-chain fatty acid esterified to the glycerol backbone. These MCFA have a shorter chain length and are ...
  2. [2]
    Applications of Medium-Chain Triglycerides in Foods - PMC
    Jun 2, 2022 · Medium-chain triglycerides (MCTs) are composed of medium-chain fatty acids (MCFAs) (Figure 1). MCTs were developed as byproducts of coconut oil ...
  3. [3]
    None
    Below is a merged summary of the GRAS Notice Details on Medium-Chain Triglycerides (MCT) based on the provided segments. To retain all information in a dense and organized manner, I will use a combination of narrative text and tables in CSV format where appropriate. The response consolidates overlapping details while preserving unique information from each segment.
  4. [4]
    Medium-chain triglycerides: Uses, Interactions, Mechanism of Action
    Jan 17, 2018 · Medium-chain triglycerides (MCTs) are triglycerides made up of a glycerol backbone and three fatty acids with an aliphatic tail of six to 12 ...
  5. [5]
    Physiological Effects of Medium-Chain Triglycerides: Potential ...
    Medium-chain triglycerides (MCT),3 containing 6–12 carbon fatty acids, differ from long-chain triglycerides (LCT), which have fatty acids of > 12 carbons, in ...
  6. [6]
    Medium-Chain Triglyceride - an overview | ScienceDirect Topics
    Medium-chain triglycerides (MCTs) are defined as mixed triacylglycerols composed of saturated fatty acids with chain lengths of 6 to 10 carbons, ...
  7. [7]
    [PDF] Medium-Chain Triglycerides - USP-NF
    Medium-Chain Triglycerides consist of a mixture of triglycerides of saturated fatty acids, mainly of caprylic acid (C8H16O2) and capric acid (C10H20O2). The ...
  8. [8]
    Applications of Medium-Chain Triglycerides in Foods - PubMed
    Jun 2, 2022 · These differences in physical properties have led, since the 1960s, to the use of MCTs to improve various lipid absorption disorders and ...Missing: malabsorption | Show results with:malabsorption
  9. [9]
    Use of Medium-Chain Triglyceride in Management of Patients with ...
    Administration of medium-chain triglyceride as the sole fat source, or as a dietary supplement, to 2 patients with severe malabsorption after massive resection ...
  10. [10]
    14.2: Lipids and Triglycerides - Chemistry LibreTexts
    Jun 9, 2019 · One type of lipid is called a triglyceride, an ester derived from glycerol combined with three fatty acid molecules.
  11. [11]
    Triglyceride - an overview | ScienceDirect Topics
    A triglyceride (TG) molecule consists of a glycerol backbone esterified with three fatty acids. Triglycerides are the main constituent of vegetable and animal ...
  12. [12]
    Tricaprylin | C27H50O6 | CID 10850 - PubChem - NIH
    Tricaprylin | C27H50O6 | CID 10850 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities ...
  13. [13]
    Coconut-sourced MCT oil: its potential health benefits beyond ...
    May 2, 2024 · The development of MCTs is dated back to the early 1950s when researchers began exploring the nutritional properties of different types of ...
  14. [14]
    Relationships Between Volatile Compounds, Storage Conditions ...
    The chief volatile compounds, quantitatively, were identified as caproic, caprylic, capric, and lauric acids, nonanone, undecanone, tridecanone, and ...
  15. [15]
    Measuring the Antimicrobial Activity of Lauric Acid against Various ...
    Lauric acid (LA) has a broad spectrum of anti-microbiological activities against enveloped viruses and various bacteria, and might be useful to protect against ...
  16. [16]
    Ketosis After Intake of Coconut Oil and Caprylic Acid—With ... - NIH
    Apr 15, 2020 · In the current article the concepts MCFA/MCT will refer to C6–C12, but while C6 only constitutes <1% of coconut oil, and is rarely used in ...
  17. [17]
    Role Medium-Chain Fatty Acids in the Lipid Metabolism of Infants
    Medium-chain fatty acids (8:0–14:0) account for 7–23% of the total FAs in human milk, and 12:0 and 14:0 are predominant, accounting for approximately 5% and 6%, ...
  18. [18]
    Fatty acids in bovine milk fat - PMC - NIH
    Jun 11, 2008 · Myristic acid (14:0) and stearic acid (18:0) make up 11 and 12% by weight, respectively. Of the saturated fatty acids, 10.9% are short-chain ...
  19. [19]
    (PDF) Fractionated coconut oil and MCT oil production
    PDF | We recently discovered that mediumchain triglyceride (MCT) oils with fatty acid compositions that cannot possibly be derived from native coconut.
  20. [20]
    MCT Extraction From Coconut & PKO | Pemac Projects Pvt Ltd
    MCT extraction involves hydrolysis, fatty acid distillation, purification, and then converting medium chain fatty acids to MCT oil by adding glycerol.
  21. [21]
    Enzymatic Interesterification - AOCS
    Enzymatic interesterification is a process in which a lipase enzyme is used to catalyse the exchange of fatty acids attached to the glycerol backbone of a fat.
  22. [22]
    Incrementing MCT Character of Coconut Oil Using Enzyme ... - J-Stage
    Abstract: The fatty acid composition of coconut oil was modified using enzyme catalyzed interesterification with the aim of obtaining a product more alike to ...
  23. [23]
    A Review of Medium-Chain Fatty Acid Production - MDPI
    In the first nine months of 2020, five additional MCFA-producing bacteria have been isolated. Caproicibacter fermentans is a C6-producing bacterium isolated ...Missing: onwards | Show results with:onwards
  24. [24]
    Sustainable production of medium chain fatty acids (MCFA) with an ...
    Chain elongation is the process by which bacteria convert ethanol and short chain fatty acids (SCFA) into medium chain fatty acids (MCFA).
  25. [25]
    Recent advances in microbial production of medium chain fatty acid ...
    This review comprehensively summarizes current advances in microbial MCFA production from renewable resources.Review · 3. Mcfa Producers · 3.1. Natural Mcfa Producers<|separator|>
  26. [26]
    MCT Oil 101: A Review of Medium-Chain Triglycerides - Healthline
    Mar 10, 2023 · Medium-chain triglycerides are metabolized differently​​ Given the shorter chain length of MCTs, they may be rapidly broken down and absorbed ...What it is · Metabolism of MCTs · Sources · MCT oil
  27. [27]
    All About MCT Oil - Composition, Varieties, Benefits, Uses, and ...
    Sep 1, 2020 · There are other types of MCT Oils available in varying ratios, such as '70/30′ (70:30 ratio of C8 and C10 fatty acids). Is There A Difference ...
  28. [28]
    Caprylic-capric triglyceride (mct) - Interfat
    The product obtained has a melting point of about 7 ° C. When in liquid form ... Also known as MCT (medium chain triglyceride). It has an almost equal ...
  29. [29]
    [PDF] SAFETY DATA SHEET MCT OIL
    Melting point, °C: <-5. Boiling point, °C: >300. Flash point, °C: >220. Vapor pressure at 20 °C,. hPa: <0.00001. Density at 20 °C, g/cm3: 0.95. Solubility in ...
  30. [30]
    [PDF] SPECIFICATION SHEET MCT-MEDIUM CHAIN TRIGLYCERIDE
    MCT-MEDIUM CHAIN TRIGLYCERIDE. Characteristics. Specifications. Min. Max. Fatty Acid Distribution (wt%) : -. -. C6. -. 0.5. C8. 50.0. 65.0. C10. 30.0. 50.0. C12.
  31. [31]
    Biological Function of Medium-Chain Fatty Acids and Their ... - MDPI
    Medium-chain fatty acid triglycerides (MCTs) possess antibacterial, antiviral, nutritional, and other biological activities and have demonstrated significant ...
  32. [32]
    [PDF] Medium-chain triglycerides: an - ABITEC
    Medium-chain triglycerides. (MCTs) were first introduced in 1950 for the treatment of disorders of lipid absorption. Since then a great deal has been learned.
  33. [33]
    MCT Oil vs. Coconut Oil: Understanding the Difference - Rupa Health
    May 31, 2024 · MCT oil has a high smoke point, typically around 320°F to 350°F (160°C to 177°C), making it suitable for sautéing, frying, and baking at ...
  34. [34]
    Can You Heat MCT Oil? Exploring the Science and Best Practices
    Jul 11, 2025 · MCT oil has a smoke point of approximately 320°F (160°C), which is lower than many other cooking oils, such as coconut oil (350°F) and olive oil ...
  35. [35]
    [PDF] SAFETY DATA SHEET - CORECHEM Inc.
    Apr 7, 2020 · Product Identifier: MCT (Medium Chain Triglycerides). Other Means of ... Odor: Bland. Odor Threshold: Not applicable. pH: Not applicable ...
  36. [36]
    All About MCT Oil: Benefits, Uses, and Side Effects | Ultimate Guide
    Jan 18, 2021 · Colorless or very pale yellow in appearance · Emits a mild characteristic odor · Remains in a liquid state at room temperature · Low viscosity and ...
  37. [37]
  38. [38]
  39. [39]
    Effect of Different Medium-Chain Triglycerides on Glucose ...
    This study is designed to examine the effects and mechanisms of three distinct MCTs on glucose metabolism in obese rats.Missing: 2023-2025 | Show results with:2023-2025
  40. [40]
    7 Science-Based Benefits of MCT Oil - Healthline
    Jun 2, 2025 · MCT oil can be a quick energy source and may support weight loss. It may also fight bacterial growth and aid in managing certain neurological conditions.Missing: expenditure | Show results with:expenditure<|separator|>
  41. [41]
    The Effects of Medium-Chain Triglyceride Oil Supplementation ... - NIH
    Most studies show MCT oil does not improve exercise performance or substrate utilization in healthy populations, with very little to no ergogenic effects.
  42. [42]
    Bulletproof Coffee Recipe
    5 minFeb 21, 2024 · Bulletproof Coffee, aka butter coffee or keto coffee, is a blend of high-quality coffee, MCT oil, and grass-fed ghee (or butter) that offers ...How to make Bulletproof Coffee · Is Bulletproof Coffee Good for...
  43. [43]
    Potential Health Benefits of MCT Oil
    Sep 28, 2022 · If taken in large doses, MCT oil or powder may cause abdominal pain, nausea, vomiting and diarrhea, warns DiMarino. Long-term use of MCT oil ...
  44. [44]
    The impact of medium-chain triglycerides on weight loss ... - PubMed
    The impact of medium-chain triglycerides on weight loss and metabolic health in individuals with overweight or obesity: A systematic review and meta-analysis.
  45. [45]
  46. [46]
    Synergistic Effects of Medium-Chain Triglyceride Supplementation ...
    Conclusions: MCT supplementation combined with chair-stand exercise enhances functional recovery and muscle health in post-stroke patients, supporting its role ...
  47. [47]
    Patented micro-encapsulated MCT provide a better consumer ...
    Oct 13, 2020 · MCB micro-encapsulated MCTs - especially the clean label and vegan friendly products - are ideal in several keto applications: meal ...
  48. [48]
    A systematic review and meta-analysis of medium-chain ...
    Aug 5, 2025 · The current evidence supports the notion that MCT decreases subsequent energy intake, but does not appear to affect appetite. Further research ...
  49. [49]
    MCT Oil Market | Global Market Analysis Report - 2035
    Sep 22, 2025 · The MCT oil market is projected to grow from USD 973.2 million in 2025 to USD 2,005.8 million by 2035, at a CAGR of 7.5%. Caprylic acid will ...
  50. [50]
    [PDF] ESPEN practical guideline on clinical nutrition in acute and chronic ...
    23) Patients should undergo screening for micro- and macronutrient deficiencies at least every twelve months; screening may need to occur more frequently in ...
  51. [51]
    Efficacy of supplemental MCT oil on seizure reduction of adult drug ...
    Apr 26, 2022 · Results: Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures.
  52. [52]
    Ketogenic Diet for Seizures - Epilepsy Foundation
    Oct 25, 2017 · Over half of children who go on the diet have at least a 50% reduction in the number of their seizures. Some children, usually 10-15%, even ...
  53. [53]
    Clinical Benefits of Exogenous Ketosis in Adults with Disease
    Sep 30, 2025 · Exogenous ketosis demonstrated potential benefits across multiple conditions, including Alzheimer's disease, mild cognitive impairment ...
  54. [54]
    Effects of medium chain triglyceride on insulin resistance in type 2 ...
    Aug 9, 2025 · Conclusion: With total energy and fat consumptions controlled, replacement of 50% dietary oil with MCT can improve insulin resistance.
  55. [55]
    Dose-Dependent Beneficial Effect of Ketone Supplement-Evoked ...
    Oct 18, 2023 · Previously, it has been demonstrated in male animals that exogenous ketone supplement-evoked ketosis can decrease anxiety levels in preclinical ...
  56. [56]
    A Randomized, Double-Blind, Controlled Trial Assessing If Medium ...
    The combination of aerobic exercise and MCT intake may be effective in preventing decline in muscle strength and promoting increase in muscle strength.
  57. [57]
    Medium Chain Triglycerides (Mcts) – Uses, Side Effects, and More
    Medium chain triglycerides (MCTs) are fat molecules usually made from coconut and palm kernel oils. Typical dietary fats are long-chain triglycerides.
  58. [58]
    Kollisolv® MCT 70 | Solvents / Co-solvents - BASF Pharma
    Benefits · Easy to emulsify · High solubilization capacity for lipophilic drugs · Suitable for use as solvent, solubilizer, penetration enhancer, emollient, water- ...
  59. [59]
    Kollisolv® MCT 70 - Pharma Excipients
    In stockExhibiting excellent solubilization capability and low toxicity, Kollisolv ® MCT is a medium chain triglyceride is also used as solubilizer for lipophilic drugs ...
  60. [60]
    Soybean Oil Emulsion - an overview | ScienceDirect Topics
    By the 1980s, however, medium-chain triglycerides (MCT) were introduced for the first time in a 1:1 mixture with soybean oil. This was followed in the 1990s by ...Parenteral Lipid Emulsions... · Lipids · Controversy 1: Lipid...
  61. [61]
    Parenteral Nutrition Lipid Emulsions and Potential Complications
    Aug 1, 2017 · ... MCT/LCT for the past 30 years in Europe. A number of small short ... During the 1990s, ClinOleic®20% became available and was comprised ...Soybean Oil Based Ile... · Soybean Oil And Medium Chain... · Fish-Oil (fo) Containing Ile...
  62. [62]
    Enhanced in vivo absorption and biodistribution of curcumin loaded ...
    The curcuminoid bioavailability was increased by 10.6-fold when using the MCT-emulsion. •. MCT-emulsion increased free-form curcumin concentration in rat liver ...
  63. [63]
    Development of curcumin‐loaded nanoemulsion stabilized ... - NIH
    Nov 22, 2023 · Moreover, the nanoemulsion delivery system provides high bioavailability and enhances the transportation of bioactive compounds through cell ...
  64. [64]
    Medium Chain Triglycerides in Cosmetic and Skincare A Versatile ...
    Mar 18, 2025 · It is widely used in anti-aging creams, lip balms, sunscreens, makeup removers, and hair conditioners. Medium-chain triglycerides have become ...Missing: lubricants | Show results with:lubricants
  65. [65]
    Octanoic Acid | C8H16O2 | CID 379 - PubChem - NIH
    Laboratory Chemical Safety Summary (LCSS) Datasheet. Molecular Formula. C8H16O2. Synonyms. octanoic acid; caprylic acid; 124-07-2; n-octanoic acid; Octylic acid.
  66. [66]
    Study of the impact on emissions and engine performance of diesel ...
    Jan 15, 2025 · When bio-additives are used, the amount of CO emissions decreases significantly. Using biodiesel leads to lower CO emission values due to the ...
  67. [67]
    Medium Chain Triglycerides Market Size, Growth, Trends & Share ...
    Jul 21, 2025 · The Medium Chain Triglycerides (MCT) Market is expected to reach USD 1.54 billion in 2025 and grow at a CAGR of 8.20% to reach USD 2.28 ...Missing: petroleum | Show results with:petroleum
  68. [68]
    Federal Register, Volume 59 Issue 150 (Friday, August 5, 1994)
    Aug 5, 1994 · A medium chain triglyceride containing caprylic and capric acids be affirmed as generally recognized as safe (GRAS) for use in food as a direct human food ...Missing: 1970s | Show results with:1970s
  69. [69]
    Summary of applications and notifications - Food Safety
    In accordance with the requirements laid down in the Novel Food regulation, the summaries of the applications are publicly available.Missing: MCTs | Show results with:MCTs